178 related articles for article (PubMed ID: 38349431)
21. Significance of Methylation of FBP1 Gene in Non-Small Cell Lung Cancer.
Dong Y; Huaying S; Danying W; Chihong Z; Ruibin J; Xiaojiang S; Jianguo F
Biomed Res Int; 2018; 2018():3726091. PubMed ID: 29984231
[TBL] [Abstract][Full Text] [Related]
22. Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition.
Xiao G; Lu W; Yuan J; Liu Z; Wang P; Fan H
J Transl Med; 2024 Jan; 22(1):99. PubMed ID: 38268032
[TBL] [Abstract][Full Text] [Related]
23. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
[TBL] [Abstract][Full Text] [Related]
24. Myofibrillogenesis Regulator-1 Regulates the Ubiquitin Lysosomal Pathway of Notch3 Intracellular Domain Through E3 Ubiquitin-Protein Ligase Itchy Homolog in the Metastasis of Non-Small Cell Lung Cancer.
Zhao W; Li Y; Cheng H; Wang M; Zhang Z; Cai M; Zhao C; Xi X; Zhao X; Zhao W; Yang Y; Shao R
Adv Sci (Weinh); 2024 Apr; 11(15):e2306472. PubMed ID: 38342606
[TBL] [Abstract][Full Text] [Related]
25. Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling.
Zhong D; Ru Y; Wang Q; Zhang J; Zhang J; Wei J; Wu J; Yao L; Li X; Li X
Cancer Lett; 2015 Apr; 359(1):57-64. PubMed ID: 25573345
[TBL] [Abstract][Full Text] [Related]
26. Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome.
Stephenson SEM; Costain G; Blok LER; Silk MA; Nguyen TB; Dong X; Alhuzaimi DE; Dowling JJ; Walker S; Amburgey K; Hayeems RZ; Rodan LH; Schwartz MA; Picker J; Lynch SA; Gupta A; Rasmussen KJ; Schimmenti LA; Klee EW; Niu Z; Agre KE; Chilton I; Chung WK; Revah-Politi A; Au PYB; Griffith C; Racobaldo M; Raas-Rothschild A; Ben Zeev B; Barel O; Moutton S; Morice-Picard F; Carmignac V; Cornaton J; Marle N; Devinsky O; Stimach C; Wechsler SB; Hainline BE; Sapp K; Willems M; Bruel AL; Dias KR; Evans CA; Roscioli T; Sachdev R; Temple SEL; Zhu Y; Baker JJ; Scheffer IE; Gardiner FJ; Schneider AL; Muir AM; Mefford HC; Crunk A; Heise EM; Millan F; Monaghan KG; Person R; Rhodes L; Richards S; Wentzensen IM; Cogné B; Isidor B; Nizon M; Vincent M; Besnard T; Piton A; Marcelis C; Kato K; Koyama N; Ogi T; Goh ES; Richmond C; Amor DJ; Boyce JO; Morgan AT; Hildebrand MS; Kaspi A; Bahlo M; Friðriksdóttir R; Katrínardóttir H; Sulem P; Stefánsson K; Björnsson HT; Mandelstam S; Morleo M; Mariani M; ; Scala M; Accogli A; Torella A; Capra V; Wallis M; Jansen S; Weisfisz Q; de Haan H; Sadedin S; ; Lim SC; White SM; Ascher DB; Schenck A; Lockhart PJ; Christodoulou J; Tan TY
Am J Hum Genet; 2022 Apr; 109(4):601-617. PubMed ID: 35395208
[TBL] [Abstract][Full Text] [Related]
27. E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4.
Lu C; Ning G; Si P; Zhang C; Liu W; Ge W; Cui K; Zhang R; Ge S
Biochem Cell Biol; 2021 Oct; 99(5):675-681. PubMed ID: 33529121
[TBL] [Abstract][Full Text] [Related]
28. Targeting cancer stemness mediated by BMI1 and MCL1 for non-small cell lung cancer treatment.
Lin EH; Hsu JW; Lee TF; Hsu CF; Lin TH; Jan YH; Chang HY; Cheng CM; Hsu HJ; Chen WW; Chen BH; Tsai HF; Li JJ; Huang CY; Chuang SH; Chang JM; Hsiao M; Wu CW
J Cell Mol Med; 2022 Aug; 26(15):4305-4321. PubMed ID: 35794816
[TBL] [Abstract][Full Text] [Related]
29. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S
Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290
[TBL] [Abstract][Full Text] [Related]
30. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
[No Abstract] [Full Text] [Related]
31. Aberrant FBXW7-mediated ubiquitination and degradation of ZMYND8 enhances tumor progression and stemness in bladder cancer.
Qiu F; Jin Y; Pu J; Huang Y; Hou J; Zhao X; Lu Y
Exp Cell Res; 2021 Oct; 407(2):112807. PubMed ID: 34487730
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF
Bajpai S; Jin HR; Mucha B; Diehl JA
Cancer Biol Ther; 2022 Dec; 23(1):348-357. PubMed ID: 35438057
[TBL] [Abstract][Full Text] [Related]
33. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
34. FBXW7 suppresses epithelial-mesenchymal transition and chemo-resistance of non-small-cell lung cancer cells by targeting snai1 for ubiquitin-dependent degradation.
Xiao G; Li Y; Wang M; Li X; Qin S; Sun X; Liang R; Zhang B; Du N; Xu C; Ren H; Liu D
Cell Prolif; 2018 Oct; 51(5):e12473. PubMed ID: 30094882
[TBL] [Abstract][Full Text] [Related]
35. MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation.
Jin X; Pan Y; Wang L; Zhang L; Ravichandran R; Potts PR; Jiang J; Wu H; Huang H
Oncogenesis; 2017 Apr; 6(4):e312. PubMed ID: 28394358
[TBL] [Abstract][Full Text] [Related]
36. The FBXW7 tumor suppressor inhibits breast cancer proliferation and promotes apoptosis by targeting MTDH for degradation.
Chen X; Li XY; Long M; Wang X; Gao ZW; Cui Y; Ren J; Zhang Z; Liu C; Dong K; Zhang H
Neoplasma; 2018; 65(2):201-209. PubMed ID: 29534580
[TBL] [Abstract][Full Text] [Related]
37. TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer.
Zhong T; Zhang J; Liu X; Li H
Cell Oncol (Dordr); 2023 Oct; 46(5):1493-1507. PubMed ID: 37219768
[TBL] [Abstract][Full Text] [Related]
38. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
[TBL] [Abstract][Full Text] [Related]
39. miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells.
Xiao G; Zhang B; Meng J; Wang J; Xu C; Tang SC; Li X; Zhang J; Liang R; Ren H; Sun X
Cell Cycle; 2017; 16(24):2374-2385. PubMed ID: 28949784
[TBL] [Abstract][Full Text] [Related]
40. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Xiao Y; Yin C; Wang Y; Lv H; Wang W; Huang Y; Perez-Losada J; Snijders AM; Mao JH; Zhang P
Mol Oncol; 2018 Jun; 12(6):883-895. PubMed ID: 29633504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
